These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10203053)

  • 1. Protection from pathogenic SIV challenge using multigenic DNA vaccines.
    Haigwood NL; Pierce CC; Robertson MN; Watson AJ; Montefiori DC; Rabin M; Lynch JB; Kuller L; Thompson J; Morton WR; Benveniste RE; Hu SL; Greenberg P; Mossman SP
    Immunol Lett; 1999 Mar; 66(1-3):183-8. PubMed ID: 10203053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
    Mossman SP; Pierce CC; Watson AJ; Robertson MN; Montefiori DC; Kuller L; Richardson BA; Bradshaw JD; Munn RJ; Hu SL; Greenberg PD; Benveniste RE; Haigwood NL
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):425-34. PubMed ID: 15157361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
    Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
    J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.
    Demberg T; Boyer JD; Malkevich N; Patterson LJ; Venzon D; Summers EL; Kalisz I; Kalyanaraman VS; Lee EM; Weiner DB; Robert-Guroff M
    J Virol; 2008 Nov; 82(21):10911-21. PubMed ID: 18753198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against SIVmne in macaques using multigenic DNA vaccines.
    Mossman SP; Pierce CC; Robertson MN; Watson AJ; Montefiori DC; Rabin M; Kuller L; Thompson J; Lynch JB; Morton WR; Benveniste RE; Munn R; Hu SL; Greenberg P; Haigwood NL
    J Med Primatol; 1999; 28(4-5):206-13. PubMed ID: 10593487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques.
    Polacino PS; Stallard V; Klaniecki JE; Pennathur S; Montefiori DC; Langlois AJ; Richardson BA; Morton WR; Benveniste RE; Hu SL
    J Virol; 1999 Oct; 73(10):8201-15. PubMed ID: 10482571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
    Seth A; Ourmanov I; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Wyatt L; Carroll M; Moss B; Venzon D; Letvin NL; Hirsch VM
    J Virol; 2000 Mar; 74(6):2502-9. PubMed ID: 10684264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific proliferative T cell responses and antibodies elicited by vaccination with simian immunodeficiency virus Nef do not confer protection against virus challenge.
    Wade-Evans AM; Stott J; Hanke T; Stebbings R; Berry N; Lines J; Sangster R; Silvera P; Walker B; MacManus S; Davis G; Cowie J; Arnold C; Hull R; Almond N
    AIDS Res Hum Retroviruses; 2001 Nov; 17(16):1517-26. PubMed ID: 11709096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease.
    Fultz PN; Stallworth J; Porter D; Novak M; Anderson MJ; Morrow CD
    Virology; 2003 Oct; 315(2):425-37. PubMed ID: 14585346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.
    Mossman SP; Bex F; Berglund P; Arthos J; O'Neil SP; Riley D; Maul DH; Bruck C; Momin P; Burny A; Fultz PN; Mullins JI; Liljeström P; Hoover EA
    J Virol; 1996 Mar; 70(3):1953-60. PubMed ID: 8627721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
    J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.
    Mäkitalo B; Lundholm P; Hinkula J; Nilsson C; Karlén K; Mörner A; Sutter G; Erfle V; Heeney JL; Wahren B; Biberfeld G; Thorstensson R
    J Gen Virol; 2004 Aug; 85(Pt 8):2407-2419. PubMed ID: 15269383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.
    Michelini Z; Negri DR; Baroncelli S; Catone S; Comini A; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Rovetto C; Liljestrom P; Norley S; Heeney J; Titti F
    J Med Primatol; 2004 Oct; 33(5-6):251-61. PubMed ID: 15525326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
    Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
    J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of positive cellular and humoral immune responses by a prime-boost vaccine encoded with simian immunodeficiency virus gag/pol.
    Someya K; Ami Y; Nakasone T; Izumi Y; Matsuo K; Horibata S; Xin KQ; Yamamoto H; Okuda K; Yamamoto N; Honda M
    J Immunol; 2006 Feb; 176(3):1784-95. PubMed ID: 16424209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm.
    Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P
    AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.